Literature DB >> 7839931

Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma.

I O Olubuyide1, L S Salimonu, S O Adeniran.   

Abstract

Circulating soluble immune complexes and serum immunoglobulins (G,A and M) levels were determined in patients with primary liver cell carcinoma (PLCC) and healthy subjects by the polyethylene glycol precipitation and single radial immunodiffusion methods respectively. A considerably higher proportion of the patients than the controls had elevated levels of soluble immune complexes, IgG and IgM were significantly higher in the patients than the controls, that of IgA was lower. Correlation studies showed association between serum concentration of IgG, IgA and IgM and the levels of circulating soluble immume complexes. Several factors may influence our findings of elevated concentrations of soluble immune complexes and serum immunoglobulins G and M as well as the positive correlations between these indices. It could be as a result of increased rate of production and release of antigen from the tumour; enhanced interaction of antibody with membrane antigens at the tumour cell surface which promoted release of immune complexes or/and decreased rate of elimination of the complexes from the body of phagocytosis. That antibodies are required for the formation of immune complexes may explain our observation of increased levels of IgG and IgM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7839931

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  7 in total

1.  Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

2.  Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines.

Authors:  Ming Li; Hui Zheng; Zhi Duan; Haidan Liu; Duosha Hu; Ann Bode; Zigang Dong; Ya Cao
Journal:  Cell Mol Immunol       Date:  2011-10-31       Impact factor: 11.530

3.  Heterogeneity of aberrant immunoglobulin expression in cancer cells.

Authors:  Duosha Hu; Zhi Duan; Ming Li; Yiqun Jiang; Haidan Liu; Hui Zheng; Lili Li; Ann M Bode; Zigang Dong; Ya Cao
Journal:  Cell Mol Immunol       Date:  2011-08-22       Impact factor: 11.530

4.  Evaluation of humoral immunity in oral cancer patients from a nigerian referral centre.

Authors:  Victor I Akinmoladun; Olatubosun G Arinola; T Elumelu-Kupoluyi; Lucy O Eriba
Journal:  J Maxillofac Oral Surg       Date:  2012-09-25

5.  Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells.

Authors:  Jie Zheng; Jing Huang; Yuntao Mao; Shiqing Liu; Xin Sun; Xiaohui Zhu; Teng Ma; Li Zhang; Jiafu Ji; Youhui Zhang; C Cameron Yin; Xiaoyan Qiu
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

6.  Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Chang-Hong Yi; Hong-Lei Weng; Fei-Guo Zhou; Meng Fang; Jun Ji; Cheng Cheng; Hao Wang; Roman Liebe; Steven Dooley; Chun-Fang Gao
Journal:  Oncoimmunology       Date:  2015-07-07       Impact factor: 8.110

7.  IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.

Authors:  Na Niu; Jie Zhang; Tao Huang; Yingui Sun; Zhengshan Chen; Weining Yi; Christine Korteweg; Juping Wang; Jiang Gu
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.